Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
AverageAxcelis Technologies, Inc. (“Axcelis,” the “Company,” “we,” “us,” or “our”) designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. We believe that our Purion family of products offers the most innovative implanters available on the market today. We sell to leading semiconductor chip manufacturers worldwide. The ion implantation business represented 98.2% of our revenue in 2025, with the remaining 1.8% of revenue derived from aftermarket sales associated with other legacy processing systems.
In the company’s own words · 10-K filed Feb 26, 2026 · SEC EDGAR
Business segments
Q1 2026 · $209.9MThe company’s own SEC segment disclosure.
- New Systems$126.3M60%
- After Market$72.6M35%
- Services$10.9M5%
Axcelis Technologies, Inc. (ACLS) reported revenue of $199M in Q1 2026 (quarter ended March 31, 2026), up 3.3% from the same quarter a year earlier. That came with a gross margin of 41% and net income of $9.2M (4.6% of revenue). For the full year FY2025, revenue was $839M (−18% year on year) and net income $120M. Its largest product in 2026-Q1 was New Systems at $126M, 60% of the disclosed total, just ahead of After Market at 35%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Semiconductor Equipment & Materials
Ranks #16 of 22 by Smart Score